Long Range Acquisition Forecast FY25.
Type: Special Notice
Overview

Buyer

DEPT OF DEFENSEDEFENSE HEALTH AGENCY (DHA)
Timeline
    Description

    The Department of Defense, through the Defense Health Agency (DHA), is issuing a Special Notice regarding the Long Range Acquisition Forecast for Fiscal Year 2025. This forecast aims to inform the business community about upcoming procurement plans, including various contracting opportunities that will be periodically updated as priorities evolve. The DHA is focused on enhancing healthcare delivery and operational readiness for military personnel, with significant initiatives such as the Remote Health Readiness Program and Enterprise Medical Coding services, which are projected to have substantial contract values over the coming years. Interested vendors can access detailed information and subscribe to notifications on the sam.gov website, and for further inquiries, they may contact Marco A. Cypert at marco.a.cypert.civ@mail.mil or Kevin Hodge at kevin.d.hodge8.civ@health.mil.

    Point(s) of Contact
    Files
    Title
    Posted
    The document outlines an extensive list of existing contracts within the Defense Health Agency (DHA) set to expire in Fiscal Year 2025 (FY25) that have a high likelihood of being re-procured. It categorizes various requests for proposals (RFPs) based on distinct codes and their estimated contract values, ranging from less than $1 million to over $1 billion. The document includes a mix of technology services, maintenance support, research programs, and consulting services, indicating the diverse needs of the DHA. It emphasizes the importance of transparency in the procurement process, aiming to provide industry leaders with adequate information to strategize for future contract opportunities. Notably, specific requirements presented in bold were discussed at the Alamo ACE conference in November 2024, underscoring their significance. This compilation serves as a guide for potential suppliers to prepare for upcoming solicitations while highlighting the DHA's commitment to effectively supporting military healthcare services and innovative research. The document calls for continued validation of details currently marked as "To Be Determined" to ensure accurate planning for all stakeholders involved.
    The Alamo ACE Conference file outlines the Defense Health Agency's (DHA) efforts to enhance healthcare delivery and operational readiness within the military. It centers on the leadership of Ms. Kathleen L. Berst and RDML Tracy Farrill, emphasizing their roles in managing a substantial medical products and services portfolio. The document details DHA's strategy to streamline acquisition processes, improve industry engagement, and maintain a robust Digital Health Portfolio, aiming for superior patient and provider experiences. Key initiatives include launching an Industry Portal for better communication, establishing a Medical Devices and Equipment Program Management Office to standardize lifecycle management, and defining comprehensive digital health capabilities such as telehealth and automated coding. The MHS EHR Functional Champion role is highlighted for its integration responsibilities among various digital health projects. Overall, the file reflects DHA's commitment to timely health service delivery and modernization, aligning with the Department of Defense's broader readiness goals. The strategic approach outlined here is vital for securing future federal grants and RFPs aimed at improving military healthcare systems.
    The DHA Government Healthcare Track 2024 outlines key contract opportunities and requirements aimed at enhancing health readiness for military personnel through a series of presentations scheduled for November 20, 2024. The focus areas include the Remote Health Readiness Program, DHA Enterprise Coding, Off-Site Teleradiology Services, and IT support for medical networks. Contracts will be structured as Indefinite Delivery/Indefinite Quantity (IDIQ), with significant scopes such as the Remote Health Readiness Program estimated at $2B over ten years, and Enterprise Medical Coding services projected at $300M over five years. Each initiative aims to improve healthcare delivery standards, support military medical readiness, and optimize operations across various military treatment facilities. The document emphasizes ongoing competition and collaboration within the Defense Health Agency to enhance service delivery and establish robust support systems for military members, thereby maintaining a medically ready force.
    Lifecycle
    Title
    Type
    Special Notice
    Similar Opportunities
    Health Care Delivery Solutions (HCDS) Electronic Health Record Follow-on (MHS GENESIS)
    Buyer not available
    The Department of Defense, through the Defense Health Agency (DHA), is seeking industry input for the Health Care Delivery Solutions (HCDS) Electronic Health Record (EHR) Follow-on (MHS GENESIS) procurement. This initiative aims to modernize the DoD's healthcare management system by enhancing interoperability, optimizing patient care, and leveraging commercial technology advancements while ensuring efficient integration with the Department of Veterans Affairs (VA). The procurement process is critical for maintaining a robust electronic health record system that serves approximately 9.6 million beneficiaries and 194,000 users. Interested parties are encouraged to submit their responses to the Request for Information (RFI) by November 17, 2025, and can direct inquiries to Sonya Edom at sonya.m.edom.civ@health.mil or Gabriela Hurte at gabriela.y.hurte.civ@health.mil. The anticipated timeline includes a draft RFP in Q1 FY26 and contract awards by Q4 FY26.
    Department of Defense Pharmacy Uniform Formulary Blanket Purchase Agreement/Uniform Formulary Additional Discount Program
    Buyer not available
    The Department of Defense, through the Defense Health Agency, is soliciting quotes for the Pharmacy Uniform Formulary Blanket Purchase Agreement and the Uniform Formulary Additional Discount Program, aimed at establishing an effective pharmacy benefits program for the Military Health System. This procurement involves the evaluation and selection of pharmaceutical agents based on their clinical and cost-effectiveness, with a focus on newly approved drugs that will be reviewed by the Pharmacy and Therapeutics Committee in February 2025. Interested vendors must submit their pricing information, including National Drug Codes (NDCs), by December 19, 2024, and are encouraged to participate in a pre-quotation teleconference on December 4, 2024. For further inquiries, vendors can contact Tracy Banks at tracy.e.banks2.civ@mail.mil or Julia Trang at julia.n.trang.civ@health.mil.
    Program Executive Office, Defense Healthcare Management Systems (PEO DHMS), Commercial Solutions Opening (CSO)
    Buyer not available
    The Department of Defense, through the Defense Health Agency (DHA), is issuing a Commercial Solutions Opening (CSO) to solicit proposals for prototype projects aimed at enhancing the effectiveness of healthcare delivery for military personnel. This initiative seeks innovative solutions that improve platforms, systems, components, or materials utilized by the Department of Defense, particularly in the realm of electronic health records and data management. The CSO will remain open until July 1, 2026, and interested parties are encouraged to submit their proposals, ensuring they adhere to the guidelines outlined in the associated documents. For inquiries, potential respondents can contact Lacey Lockard at lacey.n.lockard.civ@health.mil or Elizabeth Holten at elizabeth.l.holten.civ@health.mil.
    Department of Defense Pharmacy Uniform Formulary Blanket Purchase Agreement/ Uniform Formulary Additional Discount Program
    Buyer not available
    The Department of Defense, through the Defense Health Agency (DHA), is soliciting quotes for a Blanket Purchase Agreement (BPA) and an Additional Discount Program (ADP) for pharmaceutical agents to be included in the DoD Uniform Formulary (UF). This procurement aims to establish an effective pharmacy benefits program for the Military Health System (MHS), focusing on oncological agents for myelofibrosis and antihemophilic agents, with evaluations based on clinical and cost-effectiveness. Interested vendors must submit their quotes by January 16, 2026, with a pre-quotation teleconference scheduled for November 20, 2025. For further inquiries, contact Tracy Banks at tracy.e.banks2.civ@health.mil or Stephanie Erpelding at stephanie.j.erpelding.civ@health.mil.
    Office of Small Business Programs Support Services - Amend 6
    Buyer not available
    The Department of Defense, through the Defense Health Agency (DHA), is seeking proposals for the Office of Small Business Programs Support Services under a Women-Owned Small Business (WOSB) set-aside. The contract aims to provide comprehensive operational and management support for the DHA's Office of Small Business Programs, including business execution, strategic communication, and mentor-protégé program support. This initiative is crucial for enhancing small business participation in defense acquisitions and ensuring compliance with relevant regulations. The contract, valued at up to $24,500,000, will have a base period from January 5, 2026, to January 4, 2027, with four additional one-year options, and proposals are due by December 19, 2025. Interested parties should direct inquiries to Contracting Officer Vicki L. Whiteman at vicki.l.whiteman.civ@health.mil and Contract Specialist Mary Anne Young at mary.a.young138.ctr@health.mil.
    Department of Defense Pharmacy Uniform Formulary Blanket Purchase Agreement/Uniform Formulary Additional Discount Program
    Buyer not available
    The Department of Defense (DoD) is soliciting quotes for pharmaceutical agents as part of its Uniform Formulary Blanket Purchase Agreement (UF BPA) and Uniform Formulary Additional Discount Program (UF ADP) through the Defense Health Agency (DHA). This procurement aims to establish an effective pharmacy benefits program for the Military Health System (MHS), focusing on the clinical and cost-effectiveness of drugs to determine their classification within the formulary. The P&T Committee will review newly approved drugs, including agents for pulmonary, gynecological, endocrine, atopy, skeletal muscle relaxants, and pain management, with quotes due by December 9, 2025, ahead of the committee meeting scheduled for February 4-5, 2026. Interested manufacturers should contact Stephanie Erpelding or Tracy Banks for further details and ensure compliance with submission requirements outlined in the RFQ HT9402-26-Q-9102.
    Class J&A Acquisition Contracting & Financial Support Services Bridge
    Buyer not available
    The Department of Defense, through the Defense Health Agency (DHA), is seeking acquisition and contracting advisory services under the Class J&A Acquisition Contracting & Financial Support Services Bridge opportunity. The objective is to provide innovative acquisition solutions and thought leadership, leveraging knowledge of recent Department of Defense acquisition reforms and associated legislation. These services are crucial for enhancing the efficiency and effectiveness of procurement processes within the DHA. Interested parties can reach out to Leslie Nelson at leslie.s.nelson7.civ@health.mil or call 703-681-4267 for further details regarding this opportunity.
    Engineering Management and Support Services Approved Justification and Approval
    Buyer not available
    The Department of Defense, through the Defense Health Agency (DHA), is seeking to procure Engineering Management and Support Services as outlined in the approved Justification and Approval (J&A). This procurement aims to provide essential engineering management and technical support services to enhance the operational capabilities of the DHA. Such services are critical for ensuring effective management and execution of engineering projects within the defense health sector. Interested parties can reach out to Saera Khan at saera.khan.civ@health.mil or by phone at 703-681-6507, or contact Erwin Rivera at erwin.rivera.civ@health.mil or 703-681-4300 for further information.
    Redacted J&A
    Buyer not available
    The Department of Defense, through the Defense Health Agency (DHA), is seeking professional support services as outlined in the Justification and Approval (J&A) document. The procurement aims to fulfill specific requirements related to health services, although detailed objectives are provided in the attached FAR Part 6 J&A document. These services are critical for maintaining the operational effectiveness of health programs within the military context. Interested parties can reach out to Jaclyn Svincek at jaclyn.p.svincek.civ@health.mil or Jennifer C. Jackson at jennifer.c.jackson18.civ@health.mil for further information, with the performance expected to take place in Silver Spring, MD.
    Two Phase Design Build IDIQ MATOC in Support of the Western Region
    Buyer not available
    The Department of Defense, specifically the Department of the Army, is announcing a presolicitation for a Two Phase Design Build Indefinite Delivery Indefinite Quantity (IDIQ) Multiple Award Task Order Contracts (MATOC) to support the Defense Health Agency (DHA) program in the Western Region of the United States. This procurement aims to provide design-build and repair services for military healthcare and research laboratory facilities, focusing on architectural, mechanical, electrical, instrumentation, security, and safety areas, with a total contract capacity of $249 million. The solicitation will be available on or around January 12, 2026, and interested contractors must be registered in SAM.gov to access the solicitation documents via the Procurement Integrated Enterprise Environment (PIEE) website. For further inquiries, potential bidders can contact LaRhonda Archie at larhonda.m.archie@usace.army.mil or the CT-M Inbox at ct-cproposals-medcom@usace.army.mil.